We are live on ! Find out more
KZR

Kezar Life Sciences
KZR

Delisted

KZR was delisted on the 8th of May, 2026.

Back to rankings

85 hedge funds and large institutions have $117M invested in Kezar Life Sciences in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

433% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 6

44% more funds holding

Funds holding: 59 → 85 (+26)

41% more call options, than puts

Call options by funds: $403K | Put options by funds: $286K

35% more capital invested

Capital invested by funds: $86.6M → $117M (+$30.4M)

19% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.13% less ownership

Funds ownership: 5.2% → 5.07% (-0.13%)

Holders
85
Holders Change
+26
Holders Change %
+44.07%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
25
Reduced
21
Closed
6
Calls
$403K
Puts
$286K
Net Calls
+$117K
Net Calls Change
+$117K

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$6.56M
2
Millennium Management
Millennium Management
New York
+$3.67M
3
BG
Bellevue Group
Switzerland
+$3.65M
4
BBA
Baker Bros. Advisors
New York
+$3.03M
5
CS
Candriam SCA
Luxembourg
+$3.03M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$10.9M
2
BI
BVF Inc
California
-$6.82M
3
Citadel Advisors
Citadel Advisors
Florida
-$4.57M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.56M
5
CA
CHI Advisors
New York
-$595K
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
26
Monashee Investment Management
Massachusetts
$777K +$757K +15,000 New
N
27
Nuveen
North Carolina
$689K +$110K +2,173 +20%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$527K +$26.8K +532 +6%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$520K +$183K +3,620 +56%
Arrowstreet Capital
30
Arrowstreet Capital
Massachusetts
$501K +$488K +9,670 New
Bessemer Group
31
Bessemer Group
New Jersey
$496K +$483K +9,570 New
CH
32
CVI Holdings
Delaware
$486K +$473K +9,375 New
Marshall Wace
33
Marshall Wace
United Kingdom
$423K +$413K +8,185 New
AllianceBernstein
34
AllianceBernstein
Tennessee
$404K +$307K +6,080 +356%
VEA
35
Virtus ETF Advisers
New York
$375K +$365K +7,238 New
Charles Schwab
36
Charles Schwab
California
$346K -$50.9K -1,009 -13%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$297K +$289K +5,725 New
Goldman Sachs
38
Goldman Sachs
New York
$280K +$172K +3,416 +172%
RC
39
RBF Capital
California
$275K – – –
TI
40
Trexquant Investment
Connecticut
$266K +$259K +5,130 New
Prudential Financial
41
Prudential Financial
New Jersey
$251K +$244K +4,840 New
BBVA
42
Banco Bilbao Vizcaya Argentaria
Spain
$233K +$227K +4,500 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$208K +$43.3K +859 +27%
PPA
44
Parametric Portfolio Associates
Washington
$204K +$3.48K +69 +2%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$202K -$41.2K -817 -17%
Barclays
46
Barclays
United Kingdom
$175K +$28.3K +561 +20%
Bank of America
47
Bank of America
North Carolina
$138K +$43.2K +857 +47%
PP
48
Paloma Partners
Connecticut
$133K +$130K +2,576 New
Morgan Stanley
49
Morgan Stanley
New York
$122K +$103K +2,036 +679%
Jane Street
50
Jane Street
New York
$118K +$115K +2,278 New
1
2
3 4

KZR Hedge Fund Activity: Q2 2020 in Review

85 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Kezar Life Sciences (KZR) for Q2 2020, worth a combined $117M — up 35% from $86.6M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new KZR positions and 6 closed out — a net gain of 26 holders — while 25 added to existing stakes and 21 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $6.56M. The largest seller was Victory Capital Management, cutting an estimated $10.9M.

  • 85 institutional investors held Kezar Life Sciences (KZR) as of Q2 2020, up from 59 in Q1 2020.
  • Funds reported $117M of Kezar Life Sciences stock for Q2 2020, up 35% quarter-over-quarter.
  • 32 funds opened new Kezar Life Sciences positions in Q2 2020 and 6 closed out, a net change of +26 holders.
  • The largest Kezar Life Sciences buyer in Q2 2020 was Cormorant Asset Management, an estimated $6.56M added.
  • The largest Kezar Life Sciences seller in Q2 2020 was Victory Capital Management, an estimated $10.9M sold.

Based on aggregated 13F filings for Q2 2020.